Ronda Carlisle - Concepedia

Author

Ronda Carlisle

Also Known As

Ronda Carlisle, Ronda R Carlisle, Ronda R. Carlisle

Publications

374

Citations

H-Index

Concepts

All Affiliations

Ronda Carlisle is an author at University of Alabama at Birmingham specializing in immunology, immunotherapy, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	148
2	Immunology	3	3	148
3	Immunotherapy	3	3	148
4	Pathology	2	2	103
5	Immune Surveillance	2	2	96

Ronda Carlisle

Publications

368

Citations

H-Index

Page 1

	Year	Citations
Phase I Trial of Weekly Tigatuzumab, an Agonistic Humanized Monoclonal Antibody Targeting Death Receptor 5 (DR5) Andres Forero‐Torres, Jatin J. Shah, Tina E. Wood, Cancer Biotherapy and Radiopharmaceuticals	2010	141
Phase I Study of a Plasmid DNA Vaccine Encoding MART-1 in Patients with Resected Melanoma at Risk for Relapse Pierre L. Triozzi, Wayne Aldrich, Karen O. Allen, Journal of Immunotherapy Hbsag AntigenCancer ImmunosurveillanceHbsag PlasmidMedicineMelanoma	2005	52
Phase 1 Study of Weekly Polyethylene Glycol-Camptothecin in Patients with Advanced Solid Tumors and Lymphomas James Posey, Muhammad Wasif Saif, Ronda Carlisle, Clinical Cancer Research	2005	51
Phase I Study of the Intratumoral Administration of Recombinant Canarypox Viruses Expressing B7.1 and Interleukin 12 in Patients with Metastatic Melanoma Pierre L. Triozzi, Karen O. Allen, Ronda Carlisle, Clinical Cancer Research ImmunologyImmunoeditingPathologyImmunotherapeuticsImmunotherapy	2005	51
Intratumoral Administration of a Recombinant Canarypox Virus Expressing Interleukin 12 in Patients with Metastatic Melanoma Pierre L. Triozzi, Theresa V. Strong, R. Pat Bucy, Human Gene Therapy ImmunologyImmunotherapeuticsDermatologyImmunotherapyTumor Biology	2005	45
A Phase I Study of an Anti-GD3 Monoclonal Antibody, KW-2871, in Patients with Metastatic Melanoma Andres Forero, Jatin J. Shah, Ronda Carlisle, Cancer Biotherapy and Radiopharmaceuticals	2006	28

Page 1